Literature DB >> 6827360

Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note.

J P Kapp, R L Ross, E M Tucker.   

Abstract

The ocular complications of intracarotid infusion of drugs for brain-tumor chemotherapy may be eliminated by infusion of the chemotherapeutic agent into the carotid artery above the origin of the ophthalmic artery. The authors have developed a catheter that can negotiate the carotid siphon. This catheter is not balloon-tipped but incorporates a flexible tip with an expanded end to facilitate drag by flowing blood. The exit hole is placed to allow remote manipulation of the tip by hydraulic forces. Using this catheter, the authors have been consistently able to infuse the supraophthalmic carotid artery.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827360     DOI: 10.3171/jns.1983.58.4.0616

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.

Authors:  J P Kapp; R B Vance
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

2.  Intra-arterial cisplatin for the treatment of malignant gliomas.

Authors:  H B Newton; M A Page; L Junck; H S Greenberg
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

3.  Phase I study of intracarotid PCNU.

Authors:  D J Stewart; Z Grahovac; N A Russel; H Hugenholtz; S Gupta; B C Benoit; M T Richard; J A Maroun; H S Hopkins; L Locke
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.

Authors:  A M Bremer; E Kleriga; T Q Nguyen; R Balsys; H M Northup; N Gonzalez; P Duarte; R I Miller
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

5.  Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.

Authors:  R B Vance; J P Kapp
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

6.  Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.

Authors:  G Defer; F Fauchon; M Schaison; J Chiras; P Brunet
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.